1. Academic Validation
  2. A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction

A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction

  • Science. 2024 Jul 5;385(6704):91-99. doi: 10.1126/science.adk6129.
Pamela Y Ting 1 Sneha Borikar 1 John Ryan Kerrigan 1 Noel M Thomsen 1 Eamon Aghania 1 Amelia E Hinman 1 Alejandro Reyes 2 Nicolas Pizzato 2 Barna D Fodor 2 Fabian Wu 2 Muluken S Belew 1 Xiaohong Mao 1 Jian Wang 1 Shripad Chitnis 1 Wei Niu 1 Amanda Hachey 1 Jennifer S Cobb 1 Nikolas A Savage 1 Ashley Burke 1 Joshiawa Paulk 1 Dustin Dovala 3 James Lin 3 Matthew C Clifton 3 Elizabeth Ornelas 3 Xiaolei Ma 3 Nathaniel F Ware 1 Carina C Sanchez 1 John Taraszka 1 Remi Terranova 2 Judith Knehr 2 Marc Altorfer 2 S Whitney Barnes 4 Rohan E J Beckwith 1 Jonathan M Solomon 1 Natalie A Dales 1 Andrew W Patterson 1 Jürgen Wagner 2 Tewis Bouwmeester 2 Glenn Dranoff 1 Susan C Stevenson 1 James E Bradner 1
Affiliations

Affiliations

  • 1 Novartis Biomedical Research, Cambridge, MA, USA.
  • 2 Novartis Biomedical Research, Basel, Switzerland.
  • 3 Novartis Biomedical Research, Emeryville, CA, USA.
  • 4 Novartis Biomedical Research, San Diego, CA, USA.
Abstract

Sickle cell disease (SCD) is a prevalent, life-threatening condition attributable to a heritable mutation in β-hemoglobin. Therapeutic induction of fetal hemoglobin (HbF) can ameliorate disease complications and has been intently pursued. However, safe and effective small-molecule inducers of HbF remain elusive. We report the discovery of dWIZ-1 and dWIZ-2, molecular glue degraders of the WIZ transcription factor that robustly induce HbF in erythroblasts. Phenotypic screening of a Cereblon (CRBN)-biased chemical library revealed WIZ as a previously unknown repressor of HbF. WIZ degradation is mediated by recruitment of WIZ(ZF7) to CRBN by dWIZ-1, as resolved by crystallography of the ternary complex. Pharmacological degradation of WIZ was well tolerated and induced HbF in humanized mice and cynomolgus monkeys. These findings establish WIZ degradation as a globally accessible therapeutic strategy for SCD.

Figures
Products